# Aspirin for Uncontrolled Asthma

> **NCT02906761** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 24 (actual)

## Conditions studied

- Uncontrolled Asthma

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02906761
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-15
- **Primary completion:** 2021-06-17
- **Final completion:** 2021-06-17
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02906761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02906761, "Aspirin for Uncontrolled Asthma". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02906761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*